Wells Fargo Maintains Overweight on Agilon Health, Raises Price Target to $170
StoneX Maintains Buy on Agilon Health, Raises Price Target to $145
agilon health Consensus Price Target Raised 10.90% to $123.61
5 insightful analyst questions from agilon health’s Q3 2026 earnings call
agilon health Stock What Changed After Earnings Beat And Higher 2026 Guidance
agilon health (AGL) Q3 2026 Earnings Call Transcript
agilon health to Host Virtual Investor Event "Driving Performance At Scale: The agilon Framework" on November 17, 2026
Evercore ISI Group Maintains In-Line on Agilon Health, Raises Price Target to $105
Agilon Health Inc (AGL) (Q3 2026) Earnings Call Highlights: Guidance Raised as Adjusted EBITDA ...
Agilon Health Q3 Earnings Call Highlights
agilon health, inc. Reports Third Quarter 2026 Results
Compared to Estimates, Agilon (AGL) Q3 Earnings: A Look at Key Metrics
Agilon: Q3 Earnings Snapshot
agilon health (NYSE:AGL) delivers impressive Q3 2026, full-year outlook slightly exceeds expectations
agilon health Reports Third Quarter 2026 Results
agilon health, inc. (AGL) Q3 2026 Earnings Call Transcript
Agilon Health Q3 2026 Earnings Call Transcript
Agilon Health Raises FY2026 Sales Guidance from $5.775B-$5.860B to $5.870B-$5.890B vs $5.827B Est
Agilon Health Q3 EPS $1.97 Beats $(1.46) Estimate, Sales $1.519B Beat $1.461B Estimate
Are Medical Stocks Lagging Agilon Health (AGL) This Year?
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.